PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
To evaluate the efficacy and safety of photothermal with dinitrophenyl hapten (DNP) for patients with malignant melanoma (MM), Patients with pathology confirmed stage III or IV MM were enrolled. Seventy-two patients were randomized into two groups, DNP alone group (n=36) and DNP plus photothermal therapy group (n=36). The results showed that the patients in the combination treatment group had longer median progression-free survival time (19.0m vs. 12.0m, p=0.007). No severe adverse events were observed in both groups. Thus, the combination of photothermal therapy and DNP maybe a new therapeutic strategy for patients with advanced MM.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Xiaosong Li, Nan Du, Haijun Li, Shan Long, Dianjun Chen, Feifan Zhou, Yuanyuan Xu, Fuli Wang, Wei R. Chen, "Photothermal therapy combined with dinitrophenyl hapten for the treatment of late stage malignant melanoma," Proc. SPIE 10065, Biophotonics and Immune Responses XII, 1006505 (20 February 2017); https://doi.org/10.1117/12.2251090